MBX Biosciences, Inc. Common Stock (MBX) Technical Analysis & Indicators
MBX Biosciences, Inc. Common Stock (MBX) — Price $55.00 (closing price, November 3, 2026) — Healthcare — Biotechnology — NASDAQ
Latest reported results:
Technical analysis of MBX Biosciences, Inc. Common Stock (MBX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
MBX Biosciences, Inc. is a biopharmaceutical company in its clinical development phase, dedicated to pioneering precise peptide-based therapies for endocrine and metabolic conditions. Its most advanced drug candidate, MBX 2109, is a parathyroid hormone peptide prodrug currently in Phase 2 clinical trials. This medication is being evaluated as a long-duration hormone replacement treatment for individuals suffering from chronic hypoparathyroidism.